Eyconis
@eyconis.com
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members.
Eyconis's Company Logos
Eyconis's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#446BE1
Royal Blue
68, 107, 225
225, 72, 57
70, 52, 0, 12
#A8BAF1
Perano
168, 186, 241
225, 72, 80
30, 23, 0, 5
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Eyconis
Eyconis is a pioneering biotechnology company dedicated to advancing life-changing treatments for eye diseases. Founded in 2023, Eyconis focuses on transforming the delivery of clinically validated and emerging medicines for ophthalmology, addressing critical unmet needs in conditions such as wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and geographic atrophy. With an exclusive worldwide license for TransCon technology from Ascendis Pharma, Eyconis aims to develop innovative long-acting therapies that have the potential to become best-in-class solutions for patients facing vision loss.
Led by an accomplished team, including CEO Dr. Mark Bachleda and co-founder Dr. Emmett Cunningham, Eyconis combines extensive industry expertise with a commitment to transformative healthcare solutions.
The company’s cutting-edge approach not only aims to improve patient outcomes but also creates significant value for stakeholders and society. Engaged in the evolution of ophthalmic therapeutics, Eyconis is poised to impact the future of eye care significantly
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
